Key Insights

Highlights

Treatment Research

1 treatments under study, led by Assessment Of Immuneinflammatory And Metabolic Biomarkers

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07890168Recruiting

Integrated Assessment of Immune-Inflammatory and Metabolic Biomarkers for Prediction of Coronary No-Reflow Following Primary PCI in STEMI Patients

Showing all 1 trials

Research Network

Common Treatments

  • Assessment Of Immuneinflammatory And Metabolic Biomarkers1

Active Sponsors

  • Sohag University1

Related Conditions

  • Metabolic Biomarkers1
  • Integrated Assessment1
  • Immuneinflammatory1
  • Primary Percutaneous Coronary Intervention1
  • St Segment Elevation Myocardial Infarction1

Activity Timeline